Perturbed homeostasis of peripheral T cells elicits decreased susceptibility to anti-CD3-induced apoptosis in prediabetic nonobese diabetic mice

Journal of Immunology

Volumn 173, Issue 7, 2004, Pages 4407-4416

  Yang, Wen ^a,d   Hussain, Shabbir ^a   Mi, Qing Sheng ^a,e   Santamaria, Pere ^b   Delovitch, Terry L ^a,c  

^a ROBARTS RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 4; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL MODEL; APOPTOSIS; ARTICLE; DIABETES MELLITUS; DISEASE PREDISPOSITION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HISTOLOGY; IMMUNOHISTOCHEMISTRY; IMPAIRED GLUCOSE TOLERANCE; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

EID: 4644333954     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.173.7.4407     Document Type: Article

References (52)

1. Signore, A., P. Pozzilli, E. A. Gale, D. Andreani, and P. C. Beverley. 1989. The natural history of lymphocyte subsets infiltrating the pancreas of NOD mice. Diabetologia 32:282.
2. Delovitch, T. L., and B. Singh. 1997. The nonobese mouse as a model of autoimmune diabetes: immune regulation gets the NOD. Immunity 7:727.
3. + T cells from diabetic versus prediabetic NOD.NON-Thy-1a donors. Diabetes 42:44.
4. 2-microglobulin-deficient NOD mice do not develop insulitis or diabetes. Diabetes 43:500.
5. null mice are diabetes and insulitis resistant. Diabetes 43:505.
6. + T cells in initiation of insulin-dependent diabetes mellitus. Eur. J. Immunol. 26:1762.
7. null nonobese diabetic mice. J. Immunol 157:3688.
8. Serreze, D. V., H. D. Chapman, D. S. Varnum, I. Gerling, E. H. Leiter, and L. D. Shultz. 1997. Initiation of autoimmune diabetes in NOD/Lt mice is MHC class I-dependent. J. Immunol. 157:3978.
9. Wong, F. S., J. Karttunen, C. Dumont, L. Wen, I. Visintin, I. M. Pilip, N. Shastri, E. G. Pamer, and C. A. Janeway. 1999. Identification of an MHC class I-restricted autoantigen in type 1 diabetes by screening an organ-specific cDNA library. Nat. Med. 5:1026.
10. Verdaguer, J., D. Schmidt, A. Amrani, B. Anderson, N. Averill, and P. Santamaria. 1997. Spontaneous autoimmune diabetes in monoclonal T cell nonobese diabetic mice. J. Exp. Med. 186:1663.
11. Krammer, P. H., I. Behrmann, P. Daniel, J. Dhein, and K. M. Debatin. 1994. Regulation of apoptosis in the immune system. Curr. Opin. Immunol. 6:279.
12. Rocha, B., and H. V. Boehmer. 1991. Peripheral selection of the T cell repertoire. Science 251:1225.
13. Parijs, L. V., and A. K. Abbas. 1996. Role of Fas-mediated cell death in the regulation of immune responses. Curr. Opin. Immunol. 8:355.
14. Kishimoto, H., and J. Sprent. 2001. A defect in central tolerance in NOD mice. Nat. Immunol. 2:1025.
15. Lamhamedi-Cherradi, S. E., J. J. Luan, L. Eloy, G. Fluteau, J. F. Bach, and H. J. Garchon. 1998. Resistance of T cells to apoptosis in autoimmune diabetic (NOD) mice is increased early in life and is associated with dysregulated expression of Bcl-x. Diabetologia 41:178.
16. Martins, T. C., and A. P. Aguas. 1998. Involvement of c-myc in the resistance of non-obese diabetic mice to glucocorticoid-induced apoptosis. Immunology 95:377.
17. Colucci, F., C. M. Cilio, K. Lejon, C. P. Goncalves, M. L. Bergman, and D. Holmberg. 1996. Programmed cell death in the pathogenesis of murine IDDM: resistance to apoptosis induced in lymphocytes by cyclophosphamide. J. Autoimmun. 9:271.
18. -/- mice display T cell-apoptosis resistance resembling that ascribed to autoimmune-prone non-obese diabetic (NOD) mice. J. Autoimmun. 16:105.
19. Decallonne, B., E. V. Etten, A. Giulietti, K. Casteels, L. Overbergh, R. Bouillon, and C. Mathieu. 2003. Defect in activation-induce death in non-obese diabetic (NOD) T lymphocytes. J. Autoimmun. 20:219.
20. + T cells is associated with defective peripheral tolerance in nonobese diabetic mice. Clin. Immunol. 107:103.
21. Cosimi, A. B., R. B. Colvin, R. C. Burton, R. H. Rubin, G. Goldstein, P. C. Kung, W. P. Hansen, F. L. Delmonico, and P. S. Russell. 1981. Use of monoclonal antibodies to T-cell subsets for immunologic monitoring and treatment in recipients of renal allografts. N. Engl. J. Med. 305:308.
22. Ortho Multicenter Transplant Study Group. 1985. A randomized clinical trial of OKT3 monoclonal antibody for acute rejection of cadaveric renal transplants. N. Engl. J. Med. 313:337.
23. Chatenoud, L., E. Thervet, J. Primo, and J. F. Bach. 1994. Anti-CD3 antibody induces long-term remission of overt autoimmunity in nonobese diabetic mice. Proc. Natl. Acad. Sci. USA 91:123.
24. Chatenoud, L., J. Primo, and J. F. Bach. 1997. CD3 antibody-induced dominant self-tolerance in overtly diabetic NOD mice. J. Immunol. 158:2947.
25. Tang, Q., J. A. Smith, G. L. Szot, P. Zhou, M. L. Alegre, K. J. Henriksen, C. B. Thompson, and J. A. Bluestone. 2003. CD28/B7 regulation of anti-CD3-mediated immunosuppression in vivo. J. Immunol. 170:1510.
26. Herold, K. C., W. Hagopian, J. A. Auger, E. Poumian-Ruiz, L. Taylor, D. E. Donaldson, S. Gitelman, D. M. Harlan, D. Xu, R. A. Zivin, and J. A. Bluestone. 2002. Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus. N. Engl. J. Med. 346:1692.
27. Ferran, C., K. Sheehan, M. Dy, R. Schreiber, S. Merite, P. Landais, L. Noel, G. Drau, J. A. Bluestone, J. F. Bach, and L. Chatenoud. 1990. Cytokine related syndrome following injection of anti-CD3 monoclonal antibody: further evidence for transient in vivo T cell activation. Eur. J. Immunol. 20:509.
28. Kan, E. A. R., S. D. Wright, K. Welte, and C. Y. Wang. 1986. Fc receptors on monocytes cause OKT3-treated lymphocytes to internalize T3 and to secrete IL-2. Cell. Immunol. 98:181.
29. Alegre, M. L., J. Y. Tso, H. A. Sattar, J. Smith, F. Desalle, M. Cole, and J. A. Bluestone. 1995. An anti-murine CD3 monoclonal antibody with a low affinity for Fcγ receptors suppresses transplantation responses while minimizing acute toxicity and immunogenicity. J. Immunol. 155:1544.
30. Arreaza, G. A., M. J. Cameron, A. Jaramillo, B. M. Gill, D. Hardy, K. B. Laupland, M. J. Rapoport, P. Zucker, S. Chakrabarti, S. W. Chensue, et al. 1997. Neonatal activation of CD28 signaling overcomes T cell anergy and prevents autoimmune diabetes by an IL-4-dependent mechanism. J. Clin. Invest. 100:2243.
31. Grattan, M., Q. S. Mi, C. Meagher, and T. L. Delovitch. 2002. Congenic mapping of the diabetogenic locus Idd4 to a 5.2-cm region of chromosome 11 in NOD mice: identification of two potential candidate subloci. Diabetes 51:215.
32. Prochazka, M., D. V. Serreze, W. N. Frankel, and E. H. Leiter. 1992. NOR/Lt mice: MHC-matched diabetes-resistant control strains for NOD mice. Diabetes 41:98.
33. Smith, J. A., Q. Tang, and J. A. Bluestone. 1998. Partial TCR signals delivered by FcR-nonbinding anti-CD3 monoclonal antibodies differentially regulate individual Th subsets. J. Immunol. 160:4841.
34. Herold, K. C., J. B. Burton, F. Francois, E. Poumian-Ruiz, M. Glandt, and J. A. Bluestone. 2003. Activation of human T cells by FcR nonbinding anti-CD3 mAb, hOKT3γ1 (Ala-Ala). J. Clin. Invest. 111:409.
35. Chatenoud, L., B. Salomon, and J. A. Bluestone. 2001. Suppressor T cells: they're back and critical for regulation of immunity! Immunol. Rev. 182:149.
36. Bach, J. F., and L. Chatenoud. 2001. Tolerance to islet autoantigens in type 1 diabetes. Annu. Rev. Immunol. 19:131.
37. + splenocytes that delays adoptive transfer of diabetes expresses L-selectin and high levels of CCR7. J. Immunol. 169:2461.
38. + suppressor T cells in vivo. Nat. Immunol. 3:33.
39. + regulatory T cell and effector T cells. J. Immunol. 169:750.
40. Belghith, M., J. A. Bluestone, S. Barriot, J. Megret, J. F. Bach, and L. Chatenoud. 2003. TGF-β-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes. Nat. Med. 9:1202.
41. ras activation. J. Exp. Med. 177:1221.
42. Salojin, K. V., J. Zhang, M. Cameron, B. Gill, G. Arreaza, A. Ochi, and T. L. Delovitch. 1997. Impaired plasma membrane targeting of Grb-2 murine son of sevenless (mSOS) complex and differential activation of the Fyn-T cell receptor (TCR)-ξ-Cbl pathway mediate T cell hyporesponsiveness in autoimmune nonobese diabetic mice. J. Exp. Med. 186:887.
43. Salojin, K. V., J. Zhang, J. Madrenas, and T. L. Delovitch. 1998. T-cell anergy and altered T-cell receptor signaling: effects on autoimmune disease. Immunol. Today 19:468.
44. Christen, U., T. Wolfe, U. Mohrle, A. C. Hughes, E. Rodrigo, E. A. Green, R. A. Flavell, and M. G. V. Herrath. 2001. A dual role for TNF-α in type 1 diabetes: islet-specific expression abrogates the ongoing autoimmune process when induced late but not early during pathogenesis. J. Immunol. 166:7023.
45. Bagley, J., T. Sawada, Y. Wu, and J. Lacomini. 2000. A critical role for interleukin 4 in activating alloreactive CD4 T cells. Nat. Immunol. 1:257.
46. Zhang, J., T. Bardos, Q. Shao, J. Tschopp, K. Mikecz, T. T. Glant, and A. Finnegan. IL-4 potentiates activated T cell apoptosis via an IL-2-dependent mechanism. J. Immunol. 170:3495.
47. Refaeli, Y., L. V. Parijs, S. I. Alexander, and A. K. Abbas. 2002. Interferon γ is required for activation-induced death of T lymphocytes. J. Exp. Med. 196:999.
48. Trembleau, S., G. Penna, S. Gregori, N. Giarratana, and L. Adorini. 2003. IL-12 administration accelerates autoimmune diabetes in both wild-type and IFN-γ-deficient nonobese diabetic mice, revealing pathogenic and protective effects of IL-12-induced IFN-γ. J. Immunol. 170:5491.
49. Estaquier, B. J., and J. C. Ameisen. 1997. A role for T-helper type-1 and type-2 cytokines in the regulation of human monocyte apoptosis. Blood 90:1618.
50. Sobel, D. O., J. Han, J. Williams, J. W. Yoon, H. S. Jun, and B. Ahvazi. 2002. γ Interferon paradoxically inhibits the development of diabetes in the NOD mouse. J. Autoimmunity 19:129.
51. Ayala, A., C. S. Chung, G. Y. Song, and I. H. Chaudry. 2001. IL-10 mediation of activation-induced TH1 cell apoptosis and lymphoid dysfunction in polymicrobial sepsis. Cytokine 14:37.
52. Estaquier, J., M. Marguerite, F. Sahuc, N. Bessis, C. Auriault, and J. C. Ameisen. 1997. Interleukin-10-mediated T cell apoptosis during the T helper type 2 cytokine response in murine Schistosoma mansoni parasite infection. Eur. Cytokine Network 8:153.